Month: March 2019

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Mental Health Disorders Up After Head & Neck […]

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Kidney Disease Affects Revascularization Outcomes WEDNESDAY, Feb. 27, […]

Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Performance Improvement Sustained After DBT Adoption THURSDAY, Feb. […]

Here are what the editors at HealthDay consider to be the most important developments in Radiology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Advanced Echocardiographic Training Requirements Issued THURSDAY, Feb. 28, […]

Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Overlapping Surgery Appears Safe for Common Procedures TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. 2014 to 2017 Saw Improvement in Burnout […]

Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Risk Factors ID’d for Site Infection After Orthopedic […]

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rate of Opioid Rx Stable After Pediatric […]

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA: Pulmonary Embolism Risk Up With Tofacitinib 10 […]

Decreased risk seen for daunorubicin versus doxorubicin among survivors of childhood cancer

Drivers testing positive for prescription opioids more than twice as likely to initiate fatal two-vehicle crash

Risk for new infection largely due to partners’ genital HPV infection, not virus detectable on hands

Hazard ratio for developing CTS significantly increased for Sjögren syndrome, rheumatoid arthritis

Heavy smokers have reduced sensitivity for all spatial frequencies, color discrimination impairments

Test led to increase in number of patients with identified G7 biomarker, reduction in turnaround time

Operation possible when immersed in water and compatible with essential medical imaging

Mean decrease in HbA1c greater than that seen with health care professional support only

No antibiotics, deferred antibiotics tied to increase in bloodstream infection, all-cause mortality

Use of the tool increased asthma control assessment, creation of asthma action plans